SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125389
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:25
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-20240930.htm   iXBRL 10-Q 2482331
2 EX-31.1 atra-ex31_1.htm EX-31.1 14381
3 EX-31.2 atra-ex31_2.htm EX-31.2 14434
4 EX-32.1 atra-ex32_1.htm EX-32.1 10210
  Complete submission text file 0000950170-24-125389.txt   8630481

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20240930.xsd EX-101.SCH 1295279
71 EXTRACTED XBRL INSTANCE DOCUMENT atra-20240930_htm.xml XML 1246031
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 241448177
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)